“…A liquisolid formulation allows an insoluble drug to be solubilized, almost molecularly dispersed in a solid dosage form, which greatly enhances the dissolution rate of solubility-limiting drugs due to ameliorative wetting property and dissolution surface area, hence the oral bioavailability. There a great number of poorly water-soluble drugs have been developed into liquisolid formulations in an attempt to enhance their dissolution and/or bioavailability, including Rosuvastatin [ 195 ], Aprepitant [ 217 ], Fenofibrate [ 218 ], Curcumin [ 198 ], Indomethacin [ 219 ], Griseofulvin [ 205 ], Loperamide [ 208 ], Ketoprofen [ 220 ], Olmesartan Medoxomil [ 207 ], Loratadine [ 221 ], Nimesulide [ 222 ], Furosemide [ 223 ], Lovastatin [ 224 ], Carbamazepine [ 203 ], Telmisartan [ 200 ], Valsartan [ 225 ], and Mosapride Citrate [ 196 ].…”